Literatur

Autor(en) Titel Quelle Links
Aarbakke J, Janka-Schaub G, Elion G Thiopurine biology and pharmacology. Trends Pharmacol Sci 1997, 18: 3  
Abdollahzadeh M, Hoffman HJ, Blazer SI, Becker LE, Humphreys RP, Drake JM, Rutka JT Benign cerebellar astrocytoma in childhood: experience at the Hospital for Sick Children 1980-1992. Childs Nerv Syst 1994, 10: 380  
Abramson DH, Frank CM Second nonocular tumors in survivors of bilateral retinoblastoma: a possible age effect on radiation-related risk. [+] Ophthalmology 1998, 105: 573-9; discussion 579  
Adams RJ Prevention of stroke in sickle cell anemia. [+] The Journal of law, medicine & ethics 2014, 42: 135  
Aerts I, Sastre-Garau X, Savignoni A, Lumbroso-Le Rouic L, Thebaud-Leculée E, Frappaz D, Coze C, Thomas C, Gauthier-Villars M, L'evy-Gabriel C, Brisse HJ, Desjardins L, Doz F Results of a Multicenter Prospective Study on the Postoperative Treatment of Unilateral Retinoblastoma Following Primary Enucleation. [+] J Clin Oncol 2013 Mar 4; [Epub ahead of print]  
Agostini A, Cicardi M Hereditary and acquired C1-inhibitor deficiency: biological and clinical characteristics in 235 patients. [+] Medicine 1992l; 71: 206-15.  
Agrawal AK, Hsu E, Quirolo K, Neumayr LD, Flori HR Red blood cell transfusion in pediatric patients with severe chronic anemia: How slow is necessary? [+] Pediatric blood & cancer 2012, 58: 466  
Aguilar Martinez P, Angastiniotis M, Eleftheriou A, Gulbis B, Mañú Pereira Mdel M, Petrova-Benedict R, Corrons JL Haemoglobinopathies in Europe: health & migration policy perspectives. [+] Orphanet journal of rare diseases 2014, 9: 97  
Ahrens S, Hoffmann C, Jabar S, Braun-Munzinger G, Paulussen M, Dunst J, Rübe C, Winkelmann W, Heinecke A, Göbel U, Winkler K, Harms D, Treuner J, Jürgens H Evaluation of prognostic factors in a tumor volume-adapted treatment strategy for localized Ewing sarcoma of bone. Med Pediatr Oncol 1999, 32: 186  
Ait-Tahar K, Damm-Welk C, Burkhardt B, Zimmermann M, Klapper W, Reiter A, Pulford K, Woessmann W Correlation of the autoantibody response to the ALK oncoantigen in pediatric anaplastic lymphoma kinase-positive anaplastic large cell lymphoma with tumor dissemination and relapse risk. [+] Blood 2010, 115: 3314  
Aladjidi N, Leverger G, Leblanc T, Picat MQ, Michel G, Bertrand Y, Bader-Meunier B, Robert A, Nelken B, Gandemer V, Savel H, Stephan JL, Fouyssac F, Jeanpetit J, Thomas C, Rohrlich P, Baruchel A, Fischer A, Chêne G, Perel Y, Centre de Référence National des Cytopénies Auto-immunes de l'Enfant (CEREVANCE) New insights into childhood autoimmune hemolytic anemia: a French national observational study of 265 children. [+] Haematologica 2011, 96: 655  
Albright AL, Packer RJ, Zimmerman R, Rorke LB, Boyett J, Hammond GD Magnetic resonance scans should replace biopsies for the diagnosis of diffuse brain stem gliomas: a report from the Children's Cancer Group. Neurosurgery 1993, 33: 1026  
Albrecht S, von Schweinitz D, Waha A, Kraus J, von Deimling A, Pietsch T Loss of maternal alleles on chromosome arm 11p in hepatoblastoma. Cancer Res 1994, 54: 5041  
Albrecht S, Hartmann W, Houshdaran F, Koch A, Gartner B, Prawitt D, Zabel BU, Russo P, Von Schweinitz D, Pietsch T Allelic loss but absence of mutations in the polyspecific transporter gene BWR1A on 11p15. 5 in hepatoblastoma. [+] International journal of cancer. Journal international du cancer 2004, 111: 627  
Allen JC, Helson L High-dose cyclophosphamide chemotherapy for recurrent CNS tumors in children. [+] Journal of neurosurgery 1981, 55: 749  
Allen JC, Donahue B, DaRosso R, Nirenberg A Hyperfractionated craniospinal radiotherapy and adjuvant chemotherapy for children with newly diagnosed medulloblastoma and other primitive neuroectodermal tumors. [+] International journal of radiation oncology, biology, physics 1996, 36: 1155  
Alter BP Cancer in Fanconi anemia, 1927-2001. [+] Cancer 2003, 97: 425  
Althaus K, Najm J, Greinacher A MYH9 Related Platelet Disorders - Often Unknown and Misdiagnosed. [+] Klinische Padiatrie 2011, 223, 120  
Alter BP Fanconi anemia and the development of leukemia. [+] Best practice & research. Clinical haematology 2014, 27(3-4): 214  
Alten J, Klapper W, Leuschner I, Eckert C, Beier R, Vallo E, Krause M, Claviez A, Vieth S, Bleckmann K, Möricke A, Schrappe M, Cario G Secondary histiocytic sarcoma may cause apparent persistence or recurrence of minimal residual disease in childhood acute lymphoblastic leukemia. [+] Pediatr Blood Cancer 2015, 62: 1656  
Alvarez O, Rodriguez MM, Jordan L, Sarnaik S Renal medullary carcinoma and sickle cell trait: A systematic review. [+] Pediatric blood & cancer 2015, 62: 1694  
Ambros I, Attarbaschi A, Rumpler S, Luegmayr A, Turkof E, Gadner H, Ambros P Neuroblastoma cells provoke Schwann cell proliferation in vitro. Med Pediatr Oncol 2001, 36: 163  
Ambros P, Ambros I Pathology and biology guidelines for resectable and unresectable neuroblastic tumors and bone marrow examination guidelines. Med Pediatr Oncol 2001, 37: 492  
Ambros P, Ambros I, Kerbl R, Luegmayr A, Rumpler S, Ladenstein R, Amann G, Kovar H, Horcher E, De Bernardi B, Michon J, Gadner H Intratumoural heterogeneity of 1p deletions and MYCN amplification in neuroblastomas. Med Pediatr Oncol 2001, 36: 1  
American Psychiatric Association Statistical Manual for Mental Disorders. 2002 4th edition,  
Andrassy RJ, Chwals WJ Nutritional support of the pediatric oncology patient. Nutrition 1998, 14: 124  
Anderer G, Schrappe M, Brechlin A, Lauten M, Muti P, Welte K, Stanulla M Polymorphisms within glutathione S-transferase genes and initial response to glucocorticoids in childhood acute lymphoblastic leukaemia. Pharmacogenetics 2000, 10: 715  
Anderson FS, Kunin-Batson AS Neurocognitive late effects of chemotherapy in children: the past 10 years of research on brain structure and function. Pediatric blood & cancer 2009, 52: 159  
DeAngelis LM, Tong WP, Lin S, Fleisher M, Bertino JR Carboxypeptidase G2 rescue after high-dose methotrexate. [+] J Clin Oncol 1996, 14: 2145  
Anteby I, Ramu N, Gradstein L, Miskin H, Pe'er J, Benezra D Ocular and orbital complications following the treatment of retinoblastoma. [+] European journal of ophthalmology 1998, 8: 106  
Ardon H, De Vleeschouwer S, Van Calenbergh F, Claes L, Kramm CM, Rutkowski S, Wolff JE, Van Gool SW Adjuvant dendritic cell-based tumour vaccination for children with malignant brain tumours. [+] Pediatric blood & cancer 2010, 54: 519  
Arico M, Valsecchi M, Camitta B, Schrappe M, Chessells J, Baruchel A, Gaynon P, Silverman L, Janka-Schaub G, Kamps W, Pui C, Masera G Outcome of treatment in children with Philadelphia chromosome-positive acute lymphoblastic leukemia. N Engl J Med 2000, 342: 998  
Asmar L, Gehan E, Newton W, Webber B, Marsden H, van Unnik A, Hamoudi A, Shimada H, Tsokos M, Harms D Agreement among and within groups of pathologists in the classification of rhabdomyosarcoma and related childhood sarcomas. Report of an international study of four pathology classifications. Cancer 1994, 74: 2579  
Attarbaschi A, Mann G, Dworzak M, Trebo M, Muhlegger N, Reiter A, Horcher E, Gadner H The role of surgery in the treatment of pediatric B-cell non-Hodgkin's lymphoma. J Pediatr Surg 2002, 37: 1470  
Attarbaschi A, Mann G, Dworzak M, Trebo M, Urban C, Fink F, Horcher E, Reiter A, Riehm H, Gadner H Malignant non-Hodgkin's lymphoma of childhood and adolescence in Austria--therapy results between 1986 and 2000. Wien Klin Wochenschr 2002, 114: 978  
Attarbaschi A, Mann G, Dworzak M, Wiesbauer P, Schrappe M, Gadner H Mediastinal mass in childhood T-cell acute lymphoblastic leukemia. Med Pediatr Oncol 2002, 39: 558  
Attarbaschi A, Dworzak M, Steiner M, Urban C, Fink F, Reiter A, Gadner H, Mann G Outcome of children with primary resistant or relapsed non-Hodgkin lymphoma and mature B-cell leukemia after intensive first-line treatment: a population-based analysis of the Austrian Cooperative Study Group. Pediatr Blood Cancer 2005, 44: 70  
Attiyeh EF, London WB, Mossé YP, Wang Q, Winter C, Khazi D, McGrady PW, Seeger RC, Look AT, Shimada H, Brodeur GM, Cohn SL, Matthay KK, Maris JM, Children's Oncology Group Chromosome 1p and 11q deletions and outcome in neuroblastoma. [+] The New England journal of medicine 2005 Nov 24; 353: 2243  
Attarbaschi A, Mann G, Panzer-Grümayer R, Röttgers S, Steiner M, König M, Csinady E, Dworzak MN, Seidel M, Janousek D, Möricke A, Reichelt C, Harbott J, Schrappe M, Gadner H, Haas OA Minimal residual disease values discriminate between low and high relapse risk in children with B-cell precursor acute lymphoblastic leukemia and an intrachromosomal amplification of chromosome 21: the Austrian and German acute lymphoblastic leukemia Berlin-Frankfurt-Münster (ALL-BFM) trials. [+] Journal of clinical oncology 2008, 26: 3046  
Attarbaschi A, Panzer-Grümayer R, Mann G, Möricke A, König M, Mecklenbräuker A, Teigler-Schlegel A, Bradtke J, Harbott J, Göhring G, Stanulla M, Schrappe M, Zimmermann M, Haas OA, Austrian and German ALL-BFM (Berlin-Frankfurt-Münster) Study Group Minimal residual disease-based treatment is adequate for relapse-prone childhood acute lymphoblastic leukemia with an intrachromosomal amplification of chromosome 21: the experience of the ALL-BFM 2000 trial. [+] Klinische Padiatrie 2014, 226(6-7): 338  
Attiyeh EF, London WB, Mossé YP, Wang Q, Winter C, Khazi D, McGrady PW, Seeger RC, Look AT, Shimada H, Brodeur GM, Cohn SL, Matthay KK, Maris JM, Children's Oncology Group Chromosome 1p and 11q deletions and outcome in neuroblastoma. [+] The New England journal of medicine 2005 Nov 24; 353: 2243  
Auerbach AD Fanconi anemia and its diagnosis. [+] Mutat Res 2009, 668(1-2): 4  
42 items found

Die Literatur-Datenbank ist alphabetisch nach dem Namen des Erstautors sortiert - bitte anklicken. Sie umfasst alle Angaben, die im Laufe der letzten Jahre von den Studienzentralen ausgewählt wurden oder die in diesem Informationsangebot referenziert werden, zum Beispiel in den Patienteninformationstexten.